Gilead Sciences
Stories
-
Gilead posts results of Phase 3 ARTISTRY-2 study of BIC/LEN versus B/F/TAF
Results for the Phase 3 ARTISTRY-2 study were first posted on ClinicalTrials.gov on November 5, 2026. The study enrolled 577 participants and completed primary data collection on October 27, 2025.
-
Gilead posts results of ARTISTRY-1 bictegravir/lenacapavir study
The study, enrolling 689 participants, compared bictegravir/lenacapavir to stable baseline regimens in virologically suppressed people with HIV-1. Results were first posted on ClinicalTrials.gov on October 21, 2026.